HCA Healthcare, Inc. (HCA) operating KPIs
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/301% below fair value
$473.19−4.89 (-1.02%)
Close on Oct 30, 2026Market cap $102.45BP/E 15.7Yield 0.61%
KPIs
Operating metrics that drive HCA Healthcare's business · fiscal year ends December 31
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q3 2026 2026-09-30 | Q2 2026 2026-06-30 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Q4 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Q4 2023 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospital Network — Number of Hospitals at End of Period2 | 189 | 190 | 189 | 190 | 191 | 191 | 192 | 190 | 187 | 188 | 188 | 186 | |
Freestanding Outpatient Surgery Centers (ASCs) | 117 | 118 | 119 | 121 | 123 | 124 | 125 | 124 | 125 | 123 | 121 | 124 | |
Freestanding Endoscopy Centers | 30 | 30 | 30 | 31 | 29 | 29 | 26 | 26 | 23 | 23 | 24 | 24 | |
Bed Capacity — Licensed Beds at End of Period3 | 50,424 | 50,550 | 50,459 | 50,436 | 50,577 | 50,485 | 50,571 | 49,985 | 49,890 | 49,844 | 49,724 | 49,588 | |
Weighted Average Beds in Service | 42,866 | 42,905 | 42,848 | 42,985 | 42,896 | 42,858 | 42,862 | 42,705 | 42,640 | 42,624 | 42,564 | 42,072 | |
Occupancy Rate — Weighted Average Beds in Service (%)(%) | 73.2% | 72.7% | 75.5% | 72.0% | 71.7% | 72.0% | 76.9% | 71.7% | 71.9% | 71.9% | 75.2% | 72.5% | |
Average Daily Census (ADC — Admitted Inpatient Beds/Day, Form 10-Q/10-K) | 29,571 | 30,829 | 29,442 | 29,266 | 29,399 | 31,518 | 29,258 | 29,247 | 29,259 | 30,567 | 29,069 | ||
Consolidated Volume — Equivalent Admissions (Inpatient + Outpatient Equivalent)8 | 1,068,119 | 1,044,384 | 1,023,575 | 1,038,269 | 1,038,799 | 1,017,994 | 1,012,090 | 1,007,623 | 1,006,106 | 994,835 | 981,521 | 974,561 | |
Consolidated Equivalent Admissions — YoY Growth (%)(%) | 2.8% | 2.6% | 1.1% | 3.0% | 3.2% | 2.3% | 3.1% | 3.4% | 5.0% | 6.0% | 7.1% | 4.6% | |
Consolidated Inpatient Admissions | 592,179 | 579,562 | 580,258 | 576,839 | 577,804 | 566,061 | 576,361 | 559,170 | 562,100 | 554,456 | 560,869 | 544,554 | |
Consolidated Inpatient Admissions — YoY Growth (%)(%) | 2.5% | 2.4% | 0.7% | 3.2% | 2.8% | 2.1% | 2.8% | 2.7% | 4.5% | 6.0% | 6.8% | 2.7% | |
Consolidated Inpatient Days (Patient Days) | 2,734,440 | 2,690,923 | 2,774,607 | 2,708,663 | 2,692,513 | 2,675,284 | 2,836,616 | 2,691,710 | 2,690,718 | 2,662,550 | 2,781,596 | 2,674,331 | |
Consolidated Inpatient Days — YoY Growth (%)(%) | 1.6% | 0.6% | -2.2% | 0.6% | 0.1% | 0.5% | 2.0% | 0.6% | 3.0% | 4.1% | 5.4% | 1.0% | |
Consolidated Equivalent Patient Days | 4,932,906 | 4,850,633 | 4,894,407 | 4,875,907 | 4,842,027 | 4,813,548 | 4,981,098 | 4,850,820 | 4,816,761 | 4,779,234 | 4,867,793 | 4,786,197 | |
Consolidated Equivalent Patient Days — YoY Growth (%)(%) | 1.9% | 0.8% | -1.7% | 0.5% | 0.5% | 0.7% | 2.3% | 1.4% | 3.5% | 4.0% | 5.7% | 2.8% | |
Average Length of Stay (ALOS, days)(days) | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
Emergency Care — Consolidated Emergency Room (ER) Visits6 | 2,607,642 | 2,526,147 | 2,509,083 | 2,511,009 | 2,477,474 | 2,439,763 | 2,518,716 | 2,498,429 | 2,446,962 | 2,414,960 | 2,428,914 | 2,452,395 | |
Consolidated ER Visits — YoY Growth (%)(%) | 5.3% | 3.5% | -0.4% | 0.5% | 1.2% | 1.0% | 3.7% | 1.9% | 4.4% | 5.3% | 7.8% | 1.6% | |
Consolidated Outpatient Surgery Cases (Hospital & ASCs) | 242,819 | 246,947 | 240,061 | 264,401 | 253,426 | 258,365 | 246,620 | 263,832 | 249,364 | 258,967 | 252,835 | 270,286 | |
Consolidated Outpatient Surgery Cases — YoY Growth (%)(%) | -4.2% | -4.4% | -2.7% | 0.2% | 1.6% | -0.2% | -2.5% | -2.4% | -2.0% | -1.8% | -1.2% | 1.8% | |
Consolidated Inpatient Surgery Cases | 136,795 | 133,041 | 133,262 | 136,961 | 138,563 | 136,122 | 133,759 | 135,643 | 135,803 | 135,860 | 133,398 | 132,417 | |
Consolidated Inpatient Surgery Cases — YoY Growth (%)(%) | -1.3% | -2.3% | -0.4% | 1.0% | 2.0% | 0.2% | 0.3% | 2.4% | 1.7% | 2.6% | 2.3% | 0.4% | |
Outpatient Revenues as a % of Patient Revenues (%)(%) | 38.4% | 33.7% | 36.6% | 39.7% | 38.3% | 38.4% | 37.3% | 37.9% | 38.2% | 38.2% | 36.9% | 38.4% | |
Unit Economics — Consolidated Revenue per Equivalent Admission ($)($)5 | 18,583 | 19,370 | 18,669 | 18,794 | 18,446 | 18,276 | 18,102 | 18,146 | 17,381 | 17,583 | 17,666 | 17,755 | |
Consolidated Revenue per Equivalent Admission — YoY Growth (%)(%) | 0.7% | 6.0% | 3.1% | 3.6% | 6.1% | 3.9% | 2.5% | 2.2% | 2.8% | 4.1% | 3.9% | 6.8% | |
Consolidated Inpatient Revenue per Admission ($)($) | 20,059 | 22,524 | 20,297 | 19,847 | 19,908 | 19,656 | 19,349 | 19,737 | 18,728 | 18,814 | 18,923 | 18,992 | |
Consolidated Inpatient Revenue per Admission — YoY Growth (%)(%) | 0.8% | 14.6% | 4.9% | 0.6% | 6.3% | 4.5% | 2.3% | 3.9% | 2.6% | 6.4% | 6.1% | 7.7% | |
Days Revenues in Accounts Receivable (DRO, Form 10-Q/10-K)(days) | 55 | 53 | 51 | 50 | 51 | 54 | 54 | 52 | 53 | 53 | 53 | ||
Consolidated Total Revenues — Reported YoY Growth (%)(%) | 8.7% | 4.3% | 9.6% | 6.4% | 5.7% | 7.9% | 10.3% | 11.2% | |||||
Same-Facility Benchmarks — Same-Facility Equivalent Admissions14 | 1,056,672 | 1,035,610 | 1,015,685 | 1,008,489 | 1,008,805 | 990,092 | 987,645 | 980,330 | 985,613 | 975,130 | 960,772 | 959,366 | |
Same-Facility Equivalent Admissions — YoY Growth (%)(%) | 3.0% | 2.7% | 1.3% | 2.5% | 2.4% | 1.7% | 2.8% | 3.1% | 4.5% | 5.2% | 5.2% | 3.9% | |
Same-Facility Total Revenues — YoY Growth (%, Form 10-Q/10-K)(%) | 9.3% | 4.5% | 9.2% | 5.8% | 5.7% | 7.1% | 9.9% | 8.8% | |||||
Same-Facility Inpatient Admissions | 588,020 | 575,979 | 576,766 | 566,249 | 567,382 | 556,544 | 568,265 | 552,610 | 558,105 | 550,610 | 555,681 | 542,628 | |
Same-Facility Inpatient Admissions — YoY Growth (%)(%) | 2.7% | 2.5% | 0.9% | 2.4% | 2.1% | 1.8% | 2.6% | 3.0% | 4.5% | 5.8% | 6.2% | 3.1% | |
Same-Facility Revenue per Equivalent Admission ($)($) | 18,614 | 19,391 | 18,692 | 18,708 | 18,390 | 18,110 | 18,047 | 18,185 | 17,311 | 17,503 | 17,569 | 17,672 | |
Same-Facility Revenue per Equivalent Admission — YoY Growth (%)(%) | 0.6% | 6.4% | 3.1% | 2.9% | 6.6% | 4.0% | 2.9% | 2.9% | 2.5% | 4.4% | 3.5% | 6.9% | |
Same-Facility Inpatient Revenue per Admission ($)($) | 20,095 | 22,566 | 20,327 | 19,875 | 19,981 | 19,576 | 19,370 | 19,835 | 18,793 | 18,845 | 18,964 | 19,025 | |
Same-Facility Inpatient Revenue per Admission — YoY Growth (%)(%) | 0.6% | 15.4% | 5.0% | 0.6% | 7.1% | 4.5% | 2.4% | 4.4% | 3.2% | 6.4% | 6.6% | 8.5% | |
Same-Facility Emergency Room (ER) Visits | 2,585,811 | 2,507,824 | 2,493,971 | 2,467,175 | 2,439,405 | 2,401,684 | 2,486,489 | 2,466,784 | 2,433,887 | 2,400,248 | 2,400,190 | 2,445,405 | |
Same-Facility ER Visits — YoY Growth (%)(%) | 5.1% | 3.6% | 0.3% | 0.5% | 1.3% | 1.3% | 4.0% | 2.4% | 4.6% | 5.5% | 7.2% | 2.1% | |
Same-Facility Outpatient Surgery Cases | 237,263 | 242,395 | 236,326 | 258,540 | 248,367 | 253,006 | 242,471 | 257,663 | 244,733 | 254,371 | 247,721 | 263,398 | |
Same-Facility Outpatient Surgery Cases — YoY Growth (%)(%) | -3.7% | -3.4% | -1.7% | -0.5% | 1.1% | -0.6% | -2.1% | -1.3% | -2.0% | -2.1% | -2.1% | 0.7% | |
Same-Facility Inpatient Surgery Cases | 135,620 | 132,312 | 132,568 | 134,971 | 136,467 | 134,307 | 132,303 | 134,482 | 134,913 | 135,129 | 132,274 | 132,056 | |
Same-Facility Inpatient Surgery Cases — YoY Growth (%)(%) | -1.4% | -2.3% | -0.3% | 0.0% | 1.4% | -0.3% | 0.2% | 2.8% | 1.6% | 2.6% | 1.7% | 1.0% | |
Hospitals by Operating Group — Total Consolidated Hospitals (Note 12 XBRL)5 | 190 | 189 | 190 | 191 | 191 | 192 | 190 | 187 | 188 | 188 | 186 | ||
American Group — Number of Hospitals | 66 | 66 | 66 | 66 | 66 | 66 | 65 | 62 | 62 | 62 | 60 | ||
Atlantic Group — Number of Hospitals | 64 | 63 | 63 | 63 | 63 | 63 | 62 | 62 | 62 | 62 | 62 | ||
National Group — Number of Hospitals | 53 | 53 | 53 | 54 | 54 | 55 | 55 | 55 | 56 | 56 | 57 | ||
Corporate and Other (including UK) — Number of Hospitals | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | ||
Geographic Presence — Total U.S. States & Countries Operated | 19 | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||
Payor Mix — Managed Care and Other Insurers Revenue($M)13 | 9,013 | 9,084 | 9,536 | 9,267 | 9,124 | 9,041 | 9,363 | 8,497 | 8,549 | 8,545 | 8,679 | ||
Managed Care and Other Insurers — Share of Total Revenues (%)(%) | 44.6% | 47.5% | 48.4% | 49.1% | 49.4% | 48.6% | 48.7% | 49.2% | |||||
Managed Medicare (Medicare Advantage) Revenue($M) | 3,424 | 3,508 | 3,478 | 3,306 | 3,352 | 3,299 | 3,099 | 2,949 | 2,913 | 3,026 | 2,861 | ||
Managed Medicare — Share of Total Revenues (%)(%) | 16.9% | 18.4% | 17.3% | 18.0% | 18.0% | 16.9% | 16.7% | 17.4% | |||||
Medicare Fee-for-Service (Traditional Medicare) Revenue($M) | 2,927 | 3,058 | 2,847 | 2,728 | 2,803 | 2,895 | 2,737 | 2,584 | 2,621 | 2,838 | 2,720 | ||
Medicare Fee-for-Service — Share of Total Revenues (%)(%) | 14.5% | 16.0% | 14.2% | 15.1% | 15.8% | 14.8% | 15.0% | 16.4% | |||||
Medicaid Fee-for-Service (including State Directed/Supplemental Payments) Revenue($M) | 2,789 | 1,444 | 1,496 | 1,783 | 1,440 | 1,190 | 1,362 | 1,127 | 1,166 | 1,000 | 1,128 | ||
Medicaid Fee-for-Service — Share of Total Revenues (%)(%) | 13.8% | 7.6% | 9.3% | 7.7% | 6.5% | 6.4% | 6.7% | 5.8% | |||||
Managed Medicaid Revenue($M) | 997 | 939 | 966 | 949 | 899 | 879 | 938 | 1,031 | 1,033 | 978 | 1,033 | ||
Managed Medicaid — Share of Total Revenues (%)(%) | 4.9% | 4.9% | 4.9% | 4.8% | 4.8% | 5.9% | 5.9% | 5.6% | |||||
International (United Kingdom) Revenue($M) | 491 | 499 | 474 | 484 | 461 | 445 | 430 | 424 | 416 | 412 | 382 | ||
International (UK) — Share of Total Revenues (%)(%) | 2.4% | 2.6% | 2.5% | 2.5% | 2.4% | 2.4% | 2.4% | 2.4% | |||||
Other Patient & Non-Patient Revenue (net of Uninsured Implicit Concessions)($M) | 589 | 577 | 716 | 644 | 526 | 572 | 356 | 875 | 794 | 540 | 500 | ||
Other Revenue — Share of Total Revenues (%)(%) | 2.9% | 3.0% | 3.4% | 2.8% | 3.1% | 5.0% | 4.6% | 3.2% | |||||
Uncompensated Care — Total Uncompensated Care Charges Forgone (Gross Charges)($M)4 | 15,076 | 13,612 | 13,333 | 12,015 | 11,625 | 10,993 | 11,660 | 10,958 | 10,611 | 10,002 | 9,910 | ||
Estimated Cost of Total Uncompensated Care (at Cost-to-Charges Ratio)($M) | 1,445 | 1,252 | 1,246 | 1,188 | 1,116 | 1,055 | 1,146 | 1,138 | 1,072 | 1,010 | 1,015 | ||
Charity Care & Indigent Care — Gross Charges Forgone($M) | 5,318 | 5,513 | 4,612 | 4,131 | 4,112 | 3,644 | 3,851 | 4,001 | 4,112 | 3,978 | 3,741 | ||
Estimated Cost of Charity Care($M) | 511 | 507 | 431 | 408 | 395 | 350 | 377 | 416 | 415 | 402 | 382 | ||
Hospital Cost-to-Charges Ratio (%)(%) | 9.2% | 10.0% | 9.7% | 9.6% | 10.3% | 10.1% | 10.1% | ||||||
Hospital Cost Structure — Salaries and Benefits Expense($M)1 | 8,581 | 8,290 | 8,283 | 8,360 | 8,364 | 8,138 | 7,997 | 7,917 | 7,861 | 7,685 | 7,707 | 7,570 | |
Salaries and Benefits — % of Revenues (%)(%) | 43.2% | 41.0% | 43.3% | 42.8% | 43.6% | 43.7% | 43.6% | 43.3% | 45.0% | 43.9% | 44.4% | 43.7% | |
Hospital Cost Structure — Supplies Expense (Medical Devices, Pharmacy & Surgical)($M)1 | 2,822 | 2,886 | 2,853 | 2,977 | 2,782 | 2,844 | 2,764 | 2,793 | 2,657 | 2,634 | 2,671 | 2,584 | |
Supplies Expense — % of Revenues (%)(%) | 14.2% | 14.3% | 14.9% | 15.3% | 14.5% | 15.3% | 15.1% | 15.3% | 15.2% | 15.1% | 15.4% | 14.9% | |
Hospital Cost Structure — Other Operating Expenses (Contract Services, Utilities, Insurance, Rent)($M)2 | 4,548 | 5,043 | 4,180 | 4,087 | 4,161 | 3,793 | 3,845 | 3,873 | 3,717 | 3,623 | 3,606 | 3,559 | |
Other Operating Expenses — % of Revenues (%)(%) | 23.0% | 24.9% | 21.9% | 20.9% | 21.8% | 20.4% | 21.0% | 21.2% | 21.2% | 20.7% | 20.9% | 20.7% | |
Total Patient Care Operating Costs (Salaries + Supplies + Other OpEx, XBRL)($M) | 16,246 | 16,335 | 16,196 | 15,638 | 15,466 | 15,439 | 15,077 | 14,761 | 14,779 | 14,502 | |||
Non-GAAP Profitability — Adjusted EBITDA($M)7 | 3,918 | 4,027 | 3,802 | 4,114 | 3,870 | 3,849 | 3,733 | 3,712 | 3,267 | 3,550 | 3,353 | 3,618 | |
Adjusted EBITDA Margin (% of Revenues)(%) | 19.7% | 19.9% | 19.9% | 21.1% | 20.2% | 20.7% | 20.4% | 20.3% | 18.7% | 20.3% | 19.3% | 20.9% | |
Adjusted Net Income Attributable to HCA Healthcare, Inc.($M) | 1,569 | 1,691 | 1,621 | 1,847 | 1,644 | 1,656 | 1,609 | 1,587 | 1,273 | 1,452 | 1,437 | 1,598 | |
Adjusted Diluted Earnings per Share ($/sh)($) | 7.22 | 7.59 | 7.15 | 8.01 | 6.96 | 6.84 | 6.45 | 6.22 | 4.90 | 5.50 | 5.36 | 5.90 | |
Depreciation and Amortization — % of Revenues (%)(%) | 4.8% | 4.6% | 4.8% | 4.7% | 4.7% | 4.7% | 4.7% | 4.6% | 4.9% | 4.7% | 4.5% | 4.5% | |
Interest Expense — % of Revenues (%)(%) | 3.1% | 3.0% | 3.1% | 2.9% | 2.9% | 3.0% | 3.0% | 2.9% | 2.9% | 2.9% | 3.0% | 2.8% | |
Income Before Income Taxes — % of Revenues (%)(%) | 11.9% | 12.3% | 12.0% | 13.7% | 12.6% | 13.0% | 12.7% | 11.7% | 10.9% | 12.8% | 13.0% | 13.6% | |
Net Income Attributable to HCA Healthcare, Inc. — % of Revenues (%)(%) | 8.0% | 8.4% | 8.5% | 9.6% | 8.6% | 8.9% | 8.8% | 7.9% | 7.3% | 8.4% | 9.2% | 9.3% | |
Professional Liability Reserves — Net Reserves (Net of Reinsurance Recoverable) at December 313 | |||||||||||||
Gross Reserves for Professional Liability Risks — Total (Balance Sheet)($M) | 2,044 | 2,131 | 2,089 | ||||||||||
Reserves for Professional Liability Risks — Non-Current($M) | 1,464 | 1,509 | 1,466 | 1,462 | 1,506 | 1,497 | 1,544 | 1,584 | 1,573 | 1,571 | 1,557 | ||
Reserves for Professional Liability Risks — Current (in Other Accrued Expenses)($M) | 578 | 587 | 532 | ||||||||||
American Group (TX, CO, KS, MO, LA, UT, ID, AK) — Segment Revenues($M)9 | 6,582 | 6,566 | 6,933 | 6,688 | 6,493 | 6,331 | 6,563 | 6,078 | 6,043 | 5,984 | 6,092 | ||
American Group — Segment Adjusted EBITDA($M) | 1,369 | 1,414 | 1,720 | 1,580 | 1,578 | 1,418 | 1,634 | 1,364 | 1,413 | 1,318 | |||
American Group — Salaries and Benefits($M) | 2,287 | 2,277 | 2,305 | 2,275 | 2,216 | 2,196 | 2,194 | 2,176 | 2,110 | ||||
American Group — Supplies Expense($M) | 1,084 | 1,059 | 1,123 | 1,053 | 1,067 | 1,020 | 1,070 | 1,007 | 978 | ||||
American Group — Other Operating Expenses($M) | 1,859 | 1,831 | 1,806 | 1,796 | 1,649 | 1,711 | 1,678 | 1,549 | 1,560 | ||||
American Group — Total Operating Expenses (less Equity Earnings)($M) | 5,213 | 5,152 | 5,213 | 5,108 | 4,915 | 4,913 | 4,929 | 4,714 | 4,630 | ||||
American Group — Equity in Earnings of Affiliates($M) | 17 | 15 | 21 | 16 | 17 | 14 | 13 | 18 | 18 | ||||
American Group — Depreciation and Amortization($M) | 296 | 295 | 292 | 283 | 277 | 279 | 284 | 277 | 267 | 255 | 252 | ||
American Group — Segment Total Assets($M) | 21,385 | 21,251 | 21,217 | 20,889 | 20,900 | 20,614 | 20,714 | 19,786 | |||||
American Group — Goodwill and Intangible Assets($M) | 5,688 | 5,586 | 5,478 | ||||||||||
Atlantic Group (FL, TN, NC, SC, VA, NH, KY) — Segment Revenues($M)9 | 7,573 | 6,363 | 6,278 | 6,142 | 6,122 | 6,167 | 5,951 | 5,738 | 5,881 | 5,810 | 5,550 | ||
Atlantic Group — Segment Adjusted EBITDA($M) | 1,827 | 1,439 | 1,489 | 1,339 | 1,352 | 1,462 | 1,239 | 1,135 | 1,305 | 1,259 | |||
Atlantic Group — Salaries and Benefits($M) | 2,293 | 2,286 | 2,273 | 2,288 | 2,246 | 2,216 | 2,186 | 2,190 | 2,149 | ||||
Atlantic Group — Supplies Expense($M) | 934 | 944 | 951 | 889 | 935 | 914 | 902 | 858 | 884 | ||||
Atlantic Group — Other Operating Expenses($M) | 2,520 | 1,695 | 1,565 | 1,627 | 1,590 | 1,576 | 1,625 | 1,555 | 1,544 | ||||
Atlantic Group — Total Operating Expenses (less Equity Earnings)($M) | 5,746 | 4,924 | 4,789 | 4,803 | 4,770 | 4,705 | 4,712 | 4,603 | 4,576 | ||||
Atlantic Group — Equity in Earnings of Affiliates($M) | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | ||||
Atlantic Group — Depreciation and Amortization($M) | 298 | 298 | 292 | 281 | 275 | 274 | 271 | 271 | 261 | 258 | 254 | ||
Atlantic Group — Segment Total Assets($M) | 19,374 | 18,691 | 17,945 | 17,573 | 17,365 | 17,654 | 17,168 | 16,098 | |||||
Atlantic Group — Goodwill and Intangible Assets($M) | 2,214 | 2,124 | 2,064 | ||||||||||
National Group (CA, NV, GA, FL-West, VA-North, etc.) — Segment Revenues($M)9 | 5,251 | 5,321 | 5,488 | 5,525 | 5,200 | 5,065 | 5,034 | 4,931 | 4,856 | 4,835 | 4,765 | ||
National Group — Segment Adjusted EBITDA($M) | 1,184 | 1,258 | 1,352 | 1,348 | 1,271 | 1,132 | 1,190 | 1,068 | 1,087 | 1,047 | |||
National Group — Salaries and Benefits($M) | 1,965 | 1,966 | 1,964 | 1,970 | 1,919 | 1,959 | 1,886 | 1,897 | 1,869 | ||||
National Group — Supplies Expense($M) | 773 | 763 | 805 | 742 | 755 | 741 | 718 | 696 | 693 | ||||
National Group — Other Operating Expenses($M) | 1,330 | 1,334 | 1,367 | 1,466 | 1,255 | 1,233 | 1,240 | 1,270 | 1,204 | ||||
National Group — Total Operating Expenses (less Equity Earnings)($M) | 4,067 | 4,063 | 4,136 | 4,177 | 3,929 | 3,933 | 3,844 | 3,863 | 3,769 | ||||
National Group — Equity in Earnings of Affiliates($M) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -3 | ||||
National Group — Depreciation and Amortization($M) | 238 | 236 | 230 | 226 | 223 | 226 | 220 | 214 | 211 | 212 | 213 | ||
National Group — Segment Total Assets($M) | 13,589 | 13,596 | 13,596 | 13,274 | 13,139 | 13,407 | 12,855 | 12,487 | |||||
National Group — Goodwill and Intangible Assets($M) | 1,234 | 1,237 | 1,241 | ||||||||||
Corporate and Other (including United Kingdom Operations) — Revenues($M)6 | 824 | 859 | 814 | 806 | 790 | 758 | 737 | 740 | 712 | 710 | 896 | ||
Corporate and Other — Adjusted EBITDA (Net Expense / Contribution)($M) | 353 | 309 | 447 | 397 | 352 | 279 | 351 | 300 | 255 | 271 | |||
Total Reportable Operating Segments Adjusted EBITDA (American + Atlantic + National)($M) | 4,380 | 4,111 | 4,561 | 4,267 | 4,201 | 4,012 | 4,063 | 3,567 | 3,805 | 3,624 | |||
Corporate and Other — Depreciation and Amortization($M) | 112 | 101 | 97 | 99 | 88 | 81 | 81 | 80 | 80 | 70 | 70 | ||
Corporate and Other — Total Assets($M) | 8,902 | 7,912 | 7,962 | 8,011 | 8,132 | 8,123 | 8,776 | 7,840 | |||||
Corporate and Other — Goodwill and Intangible Assets($M) | 1,157 | 1,146 | 1,162 | ||||||||||
DB Product Dimension — Other Non-Patient & Capitated Revenue($M) | 589 | 577 | 716 | 644 | 526 | 572 | 356 | 875 | 794 | 540 | 500 | ||
Hospital Peer — Universal Health Services (UHS): Total Revenues($M)2 | 4,638 | 4,495 | 4,486 | 4,495 | 4,284 | 4,100 | 4,114 | 3,963 | 3,908 | 3,844 | 3,704 | ||
Universal Health Services (UHS) — GAAP Operating Income($M) | 517 | 503 | 517 | 522 | 500 | 455 | 472 | 384 | 436 | 389 | 331 | ||
Universal Health Services (UHS) — Medical Claims & Liabilities($M) | 160 | 155 | 152 | 149 | 147 | 145 | 137 | 136 | 134 | 132 | 130 | ||
Hospital Peer — Community Health Systems (CYH): Total Revenues($M)1 | 2,825 | 2,965 | 3,106 | 3,087 | 3,133 | 3,159 | 3,265 | 3,090 | 3,140 | 3,140 | 3,182 | ||
Community Health Systems (CYH) — GAAP Operating Income($M) | 389 | 281 | 450 | 243 | 512 | 284 | 278 | -205 | 238 | 231 | 327 | ||
Post-Acute / Rehab Peer — Encompass Health Corporation (EHC): Total Revenues($M) | 1,597 | 1,587 | 1,545 | 1,478 | 1,458 | 1,455 | 1,405 | 1,351 | 1,301 | 1,316 | 1,247 | ||
Behavioral Health Peer — Acadia Healthcare Company (ACHC): Total Revenues($M) | 829 | 821 | 852 | 869 | 771 | 774 | 816 | 796 | 768 | 743 | |||
Ambulatory Surgery Peer — Surgery Partners, Inc. (SGRY): GAAP Operating Income($M) | 102 | 66 | 110 | 106 | 112 | 62 | 127 | 61 | 85 | 76 | 101 | ||
Skilled Nursing Peer — The Ensign Group (ENSG): Total Revenues($M)1 | 1,484 | 1,440 | 1,389 | 1,361 | 1,296 | 1,228 | 1,173 | 1,132 | 1,082 | 1,036 | 1,010 | 959 | |
The Ensign Group (ENSG) — GAAP Operating Income($M) | 138 | 123 | 125 | 124 | 96 | 104 | 101 | 101 | 89 | 86 | 82 | 23 | |
Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues($M)3 | 3,554 | 3,416 | 3,620 | 3,420 | 3,380 | 3,224 | 3,295 | 3,264 | 3,187 | 3,071 | 3,146 | ||
DaVita Inc. (DVA) — GAAP Operating Income($M) | 579 | 482 | 561 | 506 | 538 | 439 | 565 | 535 | 506 | 484 | 390 | ||
Quest Diagnostics (DGX) — Total Revenues($M) | 3,097 | 3,043 | 2,895 | 2,806 | 2,816 | 2,761 | 2,652 | 2,621 | 2,488 | 2,397 | 2,366 | 2,288 | |
Quest Diagnostics (DGX) — GAAP Operating Income($M) | 479 | 459 | 399 | 386 | 386 | 438 | 346 | 361 | 330 | 355 | 300 | 267 | |
Managed Care Payer Benchmarks — UnitedHealth Group (UNH): Total Revenues($M)3 | 112,032 | 111,721 | 113,215 | 113,161 | 111,616 | 109,575 | 100,807 | 100,820 | 98,855 | 99,796 | 94,427 | ||
UnitedHealth Group (UNH) — GAAP Operating Income($M) | 7,991 | 8,990 | 380 | 4,315 | 5,150 | 9,119 | 7,773 | 8,708 | 7,875 | 7,931 | 7,689 | ||
CVS Health Corporation (CVS / Aetna) — Total Revenues($M) | 106,096 | 100,426 | 105,693 | 102,871 | 98,915 | 94,588 | 97,710 | 95,428 | 91,234 | 88,437 | 93,813 | ||
CVS Health Corporation (CVS / Aetna) — GAAP Operating Income($M) | 4,703 | 4,680 | 2,112 | -3,207 | 2,381 | 3,374 | 2,368 | 832 | 3,045 | 2,271 | 3,373 | ||
U.S. Census QSS — Hospitals Taxable Employer Revenue (NAICS 622, NSA)($M)5 | 47,896 | 46,674 | 46,834 | 46,295 | 45,370 | 45,358 | 45,284 | 43,778 | 43,505 | 43,709 | 43,264 | ||
Census QSS — Ambulatory Health Care Services Revenue (NAICS 621, NSA)($M) | 414,886 | 395,174 | 407,176 | 398,164 | 389,960 | 373,423 | 380,950 | 366,854 | 362,208 | 347,178 | 347,128 | ||
Census QSS — Outpatient Care Centers Revenue (NAICS 6214, NSA)($M) | 45,108 | 44,022 | 45,300 | 42,797 | 41,832 | 40,030 | 40,602 | 37,897 | 37,227 | 36,087 | 37,030 | ||
Census QSS — Medical & Diagnostic Laboratories Revenue (NAICS 6215, NSA)($M) | 20,528 | 19,569 | 19,997 | 19,677 | 19,718 | 18,722 | 19,104 | 18,893 | 18,483 | 17,963 | 17,943 | ||
BEA Personal Consumption Expenditures — Health Care Services (SAAR) | 3,790.30 | 3,699.90 | 3,667.00 | 3,614.90 | 3,529.80 | 3,464.70 | 3,417.80 | 3,358.20 | 3,288.20 | 3,244.40 | 3,159.40 | ||
BEA Real PCE — Health Care Quantity Index (2017=100)(×) | 135.90 | 133.60 | 133.60 | 132.70 | 130.40 | 129.00 | 127.90 | 126.70 | 124.80 | 123.80 | 121.50 | ||
DB Consolidated Income Statement — Total Revenues($M)16 | 19,849 | 20,230 | 19,109 | 19,513 | 19,161 | 18,605 | 18,321 | 18,285 | 17,487 | 17,492 | 17,339 | 17,303 | |
DB Consolidated — Total Operating Costs and Expenses($M) | 17,736 | 16,822 | 16,841 | 16,743 | 16,190 | 15,994 | 16,152 | 15,581 | 15,255 | 15,092 | 14,958 | ||
DB Consolidated — General & Administrative / Other Operating Expenses($M) | 148 | 133 | 153 | 139 | 130 | 126 | 120 | 111 | 100 | 90 | 100 | ||
DB Consolidated — Depreciation and Amortization($M) | 954 | 944 | 930 | 911 | 889 | 863 | 860 | 856 | 842 | 819 | 795 | 789 | |
DB Consolidated — Equity in Earnings of Affiliates($M) | 16 | 9 | 25 | 16 | 19 | 18 | 10 | 15 | 0 | -2 | 28 | ||
DB Consolidated — Gains (Losses) on Sales of Facilities($M) | 10 | -1 | 41 | -2 | -3 | 1 | -195 | -4 | 12 | 201 | 7 | ||
DB Consolidated — Interest Expense($M) | 607 | 599 | 584 | 572 | 561 | 568 | 547 | 528 | 515 | 506 | 512 | 491 | |
DB Consolidated — Income Before Income Taxes($M) | 2,370 | 2,494 | 2,287 | 2,672 | 2,418 | 2,415 | 2,327 | 2,133 | 1,906 | 2,237 | 2,247 | 2,345 | |
DB Consolidated — Provision for Income Taxes($M) | 521 | 564 | 430 | 509 | 515 | 524 | 502 | 447 | 424 | 550 | 445 | 484 | |
DB Consolidated — Net Income (Consolidated)($M) | 1,930 | 1,857 | 2,163 | 1,903 | 1,891 | 1,825 | 1,686 | 1,482 | 1,687 | 1,802 | 1,861 | ||
DB Consolidated — Net Income Attributable to Noncontrolling Interests($M) | 270 | 231 | 237 | 285 | 260 | 238 | 215 | 248 | 212 | 226 | 211 | 254 | |
DB Consolidated — Net Income Attributable to HCA Healthcare, Inc.($M) | 1,579 | 1,699 | 1,620 | 1,878 | 1,643 | 1,653 | 1,610 | 1,438 | 1,270 | 1,461 | 1,591 | 1,607 | |
DB Consolidated — Diluted Earnings per Share ($/sh)($) | 7.27 | 7.62 | 7.15 | 8.14 | 6.96 | 6.83 | 6.45 | 5.63 | 4.88 | 5.53 | 5.93 | 5.93 | |
DB Consolidated — Basic Earnings per Share ($/sh)($) | 7.70 | 7.25 | 7.05 | 6.91 | 6.52 | 4.94 | 5.60 | 6.01 | |||||
DB Consolidated — Weighted Average Diluted Shares (millions)(M) | 217 | 223 | 227 | 231 | 236 | 242 | 249 | 255 | 260 | 264 | 268 | 271 | |
DB Consolidated — Weighted Average Basic Shares (millions)(M) | 221 | 224 | 233 | 239 | 247 | 257 | 261 | 264 | |||||
DB Consolidated — Cash Dividends Declared per Share ($/sh)($) | 0.78 | 0.78 | 0.72 | 0.72 | 0.72 | 0.72 | 0.66 | 0.66 | 0.66 | 0.66 | 0.60 | ||
DB Consolidated Balance Sheet — Total Assets($M)36 | 63,250 | 61,450 | 60,720 | 59,747 | 59,536 | 59,798 | 59,513 | 59,459 | 57,379 | 56,962 | 56,211 | ||
DB Balance Sheet — Cash and Cash Equivalents($M) | 1,013 | 940 | 1,040 | 997 | 939 | 1,060 | 1,933 | 2,888 | 831 | 1,284 | 935 | ||
DB Balance Sheet — Accounts Receivable, Net($M) | 12,281 | 11,324 | 10,867 | 10,428 | 10,459 | 11,088 | 10,751 | 9,915 | 10,239 | 10,044 | 9,958 | ||
DB Balance Sheet — Inventories($M) | 1,662 | 1,681 | 1,652 | 1,734 | 1,792 | 1,794 | 1,738 | 1,776 | 1,800 | 1,903 | 2,021 | ||
DB Balance Sheet — Other Current Assets($M) | 2,234 | 2,107 | 2,224 | 2,126 | 2,373 | 2,316 | 1,992 | 2,083 | 2,303 | 2,051 | 2,013 | ||
DB Balance Sheet — Total Current Assets($M) | 17,190 | 16,052 | 15,783 | 15,285 | 15,563 | 16,258 | 16,414 | 16,662 | 15,173 | 15,282 | 14,927 | ||
DB Balance Sheet — Property and Equipment, at Cost (Gross)($M) | 68,409 | 67,365 | 66,275 | 65,489 | 64,388 | 63,680 | 62,514 | 61,750 | 60,625 | 59,440 | 58,548 | ||
DB Balance Sheet — Accumulated Depreciation($M) | -36,593 | -35,893 | -35,134 | -34,921 | -34,265 | -33,942 | -33,100 | -32,703 | -31,986 | -31,344 | -30,833 | ||
DB Balance Sheet — Property and Equipment, Net($M) | 31,816 | 31,472 | 31,141 | 30,568 | 30,123 | 29,738 | 29,414 | 29,047 | 28,639 | 28,096 | 27,715 | ||
DB Balance Sheet — Land($M) | 3,415 | 3,295 | 3,120 | ||||||||||
DB Balance Sheet — Buildings($M) | 23,726 | 22,691 | 21,560 | ||||||||||
DB Balance Sheet — Equipment & Machinery($M) | 36,989 | 34,670 | 31,998 | ||||||||||
DB Balance Sheet — Construction in Progress($M) | 2,145 | 1,858 | 1,870 | ||||||||||
DB Balance Sheet — Right-of-Use Operating Lease Assets($M) | 2,109 | 2,094 | 2,130 | 2,115 | 2,156 | 2,132 | 2,131 | 2,201 | 2,179 | 2,211 | 2,207 | ||
Right-of-Use Finance Lease Assets (XBRL)($M) | 607 | 646 | 556 | ||||||||||
Total Lease Right-of-Use Assets (Operating + Finance, XBRL)($M) | 2,737 | 2,777 | 2,763 | ||||||||||
DB Balance Sheet — Investments of Insurance Subsidiaries($M) | 402 | 387 | 485 | 573 | 531 | 550 | 569 | 553 | 483 | 471 | 477 | ||
DB Balance Sheet — Investments in and Advances to Affiliates($M) | 813 | 615 | 633 | 654 | 654 | 657 | 662 | 705 | 702 | 736 | 756 | ||
Goodwill and Other Intangible Assets, Net (XBRL)($M) | 10,662 | 10,504 | 10,293 | 10,275 | 10,273 | 10,237 | 10,093 | 9,982 | 9,963 | 9,967 | 9,945 | ||
DB Balance Sheet — Other Long-Term Assets($M) | 258 | 326 | 255 | 277 | 236 | 226 | 230 | 309 | 240 | 199 | 184 | ||
DB Balance Sheet — Accounts Payable($M) | 4,752 | 4,806 | 4,659 | 4,552 | 4,250 | 4,488 | 4,276 | 4,235 | 4,029 | 4,735 | 4,233 | ||
Accrued Salaries and Benefits (Current, XBRL)($M) | 2,199 | 2,022 | 2,525 | 2,294 | 2,072 | 1,857 | 2,304 | 2,164 | 1,993 | 1,759 | 2,127 | ||
Other Accrued Expenses (Current, XBRL)($M) | 4,097 | 3,898 | 4,277 | 4,940 | 4,513 | 3,767 | 3,899 | 3,819 | 3,705 | 3,619 | 3,871 | ||
DB Balance Sheet — Short-Term Borrowings & Long-Term Debt Due Within One Year($M) | 6,264 | 8,532 | 4,889 | 6,110 | 5,104 | 4,698 | |||||||
DB Balance Sheet — Total Current Liabilities($M) | 17,312 | 19,258 | 16,350 | 17,896 | 15,939 | 13,631 | 15,177 | 14,900 | 14,301 | 13,141 | 12,655 | ||
DB Balance Sheet — Long-Term Debt, Less Current Portion($M) | 43,454 | 39,491 | 41,603 | 38,401 | 39,379 | 41,057 | 38,333 | 38,283 | 36,306 | 37,163 | 37,169 | ||
DB Balance Sheet — Right-of-Use Operating Lease Obligations (Non-Current)($M) | 1,834 | 1,822 | 1,853 | 1,838 | 1,881 | 1,860 | 1,863 | 1,924 | 1,894 | 1,912 | 1,903 | ||
DB Balance Sheet — Operating Lease Liabilities (Current)($M) | 352 | 343 | 363 | ||||||||||
DB Balance Sheet — Total Operating Lease Liabilities($M) | 2,205 | 2,206 | 2,266 | ||||||||||
Total Finance Lease Liabilities (XBRL)($M) | 758 | 786 | 707 | ||||||||||
Total Lease Liabilities (Operating + Finance, XBRL)($M) | 2,963 | 2,992 | 2,973 | ||||||||||
DB Balance Sheet — Retained Earnings (Accumulated Deficit)($M) | -6,310 | -5,978 | -5,724 | -5,020 | -4,087 | -3,164 | -2,115 | -1,807 | -1,170 | -1,185 | -1,352 | ||
DB Balance Sheet — Accumulated Other Comprehensive Loss($M) | -334 | -327 | -305 | -317 | -309 | -357 | -387 | -378 | -433 | -433 | -425 | ||
DB Balance Sheet — Stockholders' Deficit Attributable to HCA Healthcare, Inc.($M) | -6,642 | -6,303 | -6,027 | -5,335 | -4,394 | -3,519 | -2,499 | -2,182 | -1,600 | -1,615 | -1,774 | ||
DB Balance Sheet — Noncontrolling Interests in Consolidated Entities($M) | 3,433 | 3,325 | 3,256 | 3,176 | 3,156 | 3,081 | 3,054 | 2,968 | 2,939 | 2,885 | 2,834 | ||
DB Balance Sheet — Total Stockholders' Deficit / Equity($M) | -3,209 | -2,978 | -2,771 | -2,159 | -1,238 | -438 | 555 | 786 | 1,339 | 1,270 | 1,060 | ||
DB Balance Sheet — Common Shares Outstanding at Period-End (millions)(M) | 218 | 223 | 225 | 230 | 236 | 243 | 250 | 255 | 259 | 263 | 266 | ||
DB Consolidated Cash Flow — Net Cash Provided by Operating Activities($M)18 | 2,335 | 2,014 | 2,359 | 4,416 | 4,210 | 1,651 | 2,559 | 3,515 | 1,971 | 2,469 | 2,674 | ||
DB Cash Flow — Purchase of Property and Equipment (CapEx, excluding Acquisitions)($M) | 1,231 | 1,119 | 1,489 | 1,288 | 1,176 | 991 | 1,285 | 1,191 | 1,281 | 1,118 | 1,159 | ||
DB Cash Flow — Depreciation and Amortization($M) | 944 | 930 | 911 | 889 | 863 | 860 | 856 | 842 | 819 | 795 | 789 | ||
DB Cash Flow — Share-Based Compensation($M) | 85 | 86 | 100 | 104 | 99 | 98 | 85 | 76 | 112 | 87 | 57 | ||
DB Cash Flow — Deferred Income Taxes($M) | -166 | 435 | -1,004 | 434 | 388 | 492 | 89 | -63 | -448 | 444 | 168 | ||
DB Cash Flow — Change in Accounts Receivable($M) | -954 | -463 | -439 | 25 | 647 | -327 | -854 | 340 | -195 | -90 | -767 | ||
DB Cash Flow — Change in Accounts Payable and Accrued Expenses($M) | 551 | -990 | 637 | 705 | 324 | -1,000 | 282 | 536 | 58 | -517 | 393 | ||
DB Cash Flow — Net Cash Used in Investing Activities($M) | -1,557 | -1,282 | -1,317 | -1,388 | -1,251 | -1,032 | -1,346 | -1,352 | -1,332 | -903 | -1,597 | ||
DB Cash Flow — Sales of Hospitals and Health Care Entities($M) | 18 | 3 | 92 | 10 | 6 | 161 | 16 | 1 | 1 | 310 | 10 | ||
DB Cash Flow — Net Cash Used in Financing Activities($M) | -704 | -830 | -999 | -2,967 | -3,089 | -1,495 | -2,163 | -110 | -1,093 | -1,216 | -1,039 | ||
DB Cash Flow — Issuances of Long-Term Debt($M) | 2,994 | 0 | 3,241 | 0 | 0 | 5,233 | 0 | 3,012 | 0 | 4,483 | 4 | ||
DB Cash Flow — Repayment of Long-Term Debt($M) | 2,550 | 58 | 1,555 | 174 | 1,765 | 3,895 | 64 | 77 | 203 | 2,066 | 218 | ||
Distributions to Noncontrolling Interests (XBRL)($M) | 143 | 191 | 196 | 237 | 174 | 220 | 181 | 192 | 186 | 152 | 143 | ||
DB Cash Flow — Payment of Cash Dividends($M) | 171 | 183 | 162 | 166 | 171 | 180 | 165 | 169 | 171 | 185 | 160 | ||
DB Cash Flow — Repurchase of Common Stock ($M)($M) | 2,064 | 1,571 | 2,558 | 2,498 | 2,505 | 2,506 | 1,700 | 1,795 | 1,367 | 1,180 | 910 | ||
Common Shares Repurchased (millions, XBRL)(M) | 4.75 | 3.16 | 5.43 | 6.51 | 7.03 | 7.76 | 4.74 | 4.95 | 4.22 | 3.89 | 3.65 | ||
Average Repurchase Price per Share ($/sh, XBRL)($) | 498 | 323 | 303 | ||||||||||
DB Cash Flow — Interest Paid($M) | 594 | 569 | 511 | 622 | 535 | 539 | 533 | 462 | 405 | 538 | 432 | ||
DB Cash Flow — Income Taxes Paid($M) | 730 | -5 | 1,513 | 81 | 136 | 10 | 358 | 487 | 998 | 1 | 316 | ||
Debt Structure & Lease Maturity — Gross Debt Principal / Carrying Value (XBRL)($M)16 | 50,169 | 48,456 | 46,928 | 44,927 | 44,912 | 45,008 | 43,400 | 43,343 | 41,251 | 40,572 | 39,926 | ||
Estimated Fair Value of Total Debt (XBRL)($M) | 48,640 | 46,653 | 45,911 | 43,898 | 43,201 | 42,876 | 40,845 | 42,593 | 39,086 | 38,626 | 38,253 | ||
Senior Unsecured Notes Carrying Value (XBRL)($M) | 44,200 | 43,700 | 43,700 | 41,950 | 42,075 | 43,766 | 41,116 | 41,116 | 38,116 | 38,266 | 35,766 | ||
Commercial Paper & Short-Term Credit Facility Borrowings (XBRL)($M) | 3,890 | 3,650 | 2,207 | 1,910 | 1,778 | 0 | |||||||
Average Debt Balance During Period (MD&A)($M) | 49,228 | 47,225 | 44,400 | 44,506 | 43,746 | 41,846 | 40,292 | 40,383 | |||||
Weighted Average Stated Interest Rate on Debt (XBRL, %)(%) | 5.1% | 5.1% | 5.1% | 5.1% | 5.1% | 5.2% | 5.1% | 5.1% | 5.1% | 5.1% | 5.1% | ||
Average Effective Interest Rate on Long-Term Debt (MD&A, %)(%) | 4.9% | 5.0% | 5.1% | 4.9% | 5.1% | ||||||||
Operating Lease Maturity — Total Undiscounted Lease Payments($M) | 3,219 | 3,166 | 3,242 | ||||||||||
Operating Lease Maturity — Year 1($M) | 474 | 455 | 452 | ||||||||||
Operating Lease Maturity — Year 2($M) | 413 | 405 | 394 | ||||||||||
Operating Lease Maturity — Year 3($M) | 343 | 344 | 340 | ||||||||||
Operating Lease Maturity — Year 4($M) | 276 | 281 | 288 | ||||||||||
Operating Lease Maturity — Year 5($M) | 214 | 221 | 228 | ||||||||||
Operating Lease Maturity — Thereafter (After Year 5)($M) | 1,499 | 1,460 | 1,540 | ||||||||||
Operating Lease Weighted-Average Discount Rate (%)(%) | 5.3% | 5.1% | 4.9% | ||||||||||
Finance Lease Weighted-Average Discount Rate (%)(%) | 5.6% | 5.3% | 4.9% | ||||||||||
Unrecognized Tax Benefits Balance (Note 5 XBRL)($M) | 519 | 504 | 639 | ||||||||||
8 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Fiscal calendar: HCA Healthcare, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q3 2026 (ended September 30, 2026, filed October 27, 2026 on Form 8-K Item 2.02) for all Operating Statistics, Same-Facility metrics, Non-GAAP Adjusted EBITDA, and headline financial statements; Q2 2026 (ended June 30, 2026, filed July 28, 2026 on Form 10-Q) for 10-Q footnote disclosures (Payor Source breakdown, Uncompensated Care, Segment EBITDA/OpEx, Average Daily Census, and Days Revenues in Accounts Receivable); and Full-Year FY2025 (ended December 31, 2025, filed February 10, 2026 on Form 10-K and March 13, 2026 on DEF 14A).
- Bed & Occupancy Definition Change (Q1 2021): Beginning in the FY2020 Q4 / FY2021 Form 8-K and Form 10-K (with comparative FY2019 recast), HCA transitioned its capacity utilization metric from Weighted Average Licensed Beds to Weighted Average Beds in Service (and Occupancy Rate based on Weighted Average Beds in Service, including observation patients). Both the current Beds in Service series (FY2019–FY2026Q3) and legacy Licensed Beds occupancy series (FY2014–FY2020Q3) are preserved.
- Geographic Operating Groups (Group 4): HCA manages and reports its U.S. hospital network across three geographic operating groups — American Group (66 hospitals in Q2 2026), Atlantic Group (64 hospitals), and National Group (53 hospitals) — plus Corporate and Other (including 7–8 international hospitals in England). Segment Adjusted EBITDA and segment expense breakdowns (Salaries & benefits, Supplies, Other operating expenses) are extracted from Note 12 (Segment and Geographic Information) XBRL tags.
- Parent-Company Standalone Evaluation (Step 3): HCA Healthcare, Inc. is a holding company with no standalone parent-company operating revenue ($0 direct patient revenue; all hospitals and surgery centers are operated by consolidated subsidiaries and partnerships). Therefore, Consolidated − Standalone subtraction does not apply.
- Strict Step 4 & Step 5 Compliance: Every cell displays an exact point figure published by HCA Healthcare or official external industry sources (CMS Medicaid Enrollment Reports, Census QSS/BLS/BEA via FRED, SEC XBRL hospital peer filings), plus permitted period splits (Q4 = full year − nine months and quarterly flow = year-to-date − prior quarter year-to-date, marked in italics with formula). Bound/approximate prose figures ('approximately 2,400 ambulatory sites of care', 'approximately 47 million patient encounters', 'approximately 320,000 employees', 'more than 5,400 GME residents') are excluded from table cells and cataloged in `excluded`.
Not shown because recent periods are missing (8)
- Total outpatient sites of care ('approximately 2,400 ambulatory sites of care' / 'approximately 2,500 outpatient facilities') — Số cận ('approximately 2,400', 'approximately 2,500') — loại theo Bước 5; đã lấy số điểm chính xác tuyệt đối cho các cấu phần trọng yếu có công bố bảng: Freestanding Outpatient Surgery Centers (ASCs: 117 tại Q3 2026) và Freestanding Endoscopy Centers (30 tại Q3 2026).
- Annual patient encounters ('approximately 47 million patient encounters' in FY2025; 'approximately 44 million' in FY2024) — Số cận ('approximately 47 million', 'approximately 44 million') — loại theo Bước 5; đã có chuỗi số điểm chính xác hàng quý/năm cho Admissions (2,297,065 năm FY2025), Equivalent Admissions (4,107,152), Emergency Room Visits (9,946,962) và Inpatient/Outpatient Surgeries.
- Headquarters square footage in Nashville, TN ('approximately 2,002,000 square feet' in FY2025; 'approximately 2,031,000 square feet' in FY2022–FY2024) — Số cận ('approximately 2,002,000 square feet') — loại theo Bước 5.
- Item 1 narrative employee headcount ('approximately 320,000 employees, including approximately 90,000 part-time and PRN employees') and active staff physicians ('approximately 44,000 active and affiliated physicians') & nurses ('approximately 99,000 registered nurses') — Số cận ('approximately 320,000', 'approximately 90,000', 'approximately 44,000', 'approximately 99,000') — loại theo Bước 5; đã thay bằng bảng nhân sự chính xác tuyệt đối trong DEF 14A CEO Pay Ratio (Total Global Workforce = 316,971; Total U.S. Employees = 308,398; Total International Employees = 8,573 cuối FY2025).
- Graduate Medical Education (GME) residents & fellows ('more than 5,400 residents and fellows' / 'nearly 2,000 new residents and fellows') — Số cận ('more than 5,400', 'nearly 2,000') — loại theo Bước 5.
- HCA Healthcare Research Institute active clinical trials ('more than 500 active trials') — Số cận ('more than 500') — loại theo Bước 5.
- Behavioral & rehabilitation hospital counts in Item 1 narrative ('seven behavioral hospitals, and four rehabilitation hospitals') — Công bố bằng chữ ('seven', 'four') thay vì chữ số trong câu trích — loại theo Bước 5; đã lấy chuỗi số điểm chữ số cho Total Hospitals (190) và General Acute Care Hospitals (179).
- State hospital & bed counts in Oklahoma (2 hospitals, 756 beds in FY2016–FY2017) and Mississippi (1 hospital, 130 beds in FY2016–FY2019) — HCA đã thoái vốn toàn bộ bệnh viện tại Oklahoma (sau FY2017) và Mississippi (sau FY2019), không còn dữ liệu ở 2 năm tài chính gần nhất (FY2024–FY2025).
Data updated 2026-10-29.
Every KPI on its own page
Full history, chart, sources and a citation for each metric
1. Core Hospital Network, Patient Volume, Surgical/ER Activity & Unit Economics (Consolidated & Same-Facility, through Q3 2026)
- Hospital Network — Number of Hospitals at End of Period40 periods
- Bed Capacity — Licensed Beds at End of Period40 periods
- Consolidated Volume — Equivalent Admissions (Inpatient + Outpatient Equivalent)40 periods
- Emergency Care — Consolidated Emergency Room (ER) Visits40 periods
- Unit Economics — Consolidated Revenue per Equivalent Admission ($) ($)40 periods
- Same-Facility Benchmarks — Same-Facility Equivalent Admissions40 periods
2. Hospital & Licensed Bed Footprint by Operating Group, U.S. State & United Kingdom (Form 10-K Item 2 & XBRL)
- Hospitals by Operating Group — Total Consolidated Hospitals (Note 12 XBRL)27 periods
- Texas (TX) — Licensed Beds10 periods
- Florida (FL) — Licensed Beds10 periods
- Virginia (VA) — Licensed Beds10 periods
- Tennessee (TN) — Licensed Beds10 periods
- Colorado (CO) — Licensed Beds10 periods
- Nevada (NV) — Licensed Beds10 periods
- Georgia (GA) — Licensed Beds10 periods
- Kansas (KS) — Licensed Beds10 periods
- California (CA) — Licensed Beds10 periods
- North Carolina (NC) — Licensed Beds7 periods
- South Carolina (SC) — Licensed Beds10 periods
- Missouri (MO) — Licensed Beds10 periods
- Utah (UT) — Licensed Beds10 periods
- United Kingdom — England (International) — Licensed Beds10 periods
- New Hampshire (NH) — Licensed Beds10 periods
- Idaho (ID) — Licensed Beds10 periods
- Kentucky (KY) — Licensed Beds10 periods
- Louisiana (LA) — Licensed Beds10 periods
- Alaska (AK) — Licensed Beds10 periods
- Indiana (IN, divested in FY2025) — Licensed Beds9 periods
3. Disaggregated Revenue by Payor Source, Uncompensated Care, Operating Cost Structure & Non-GAAP Profitability
- Payor Mix — Managed Care and Other Insurers Revenue ($M)30 periods
- Uncompensated Care — Total Uncompensated Care Charges Forgone (Gross Charges) ($M)30 periods
- Hospital Cost Structure — Salaries and Benefits Expense ($M)40 periods
- Hospital Cost Structure — Supplies Expense (Medical Devices, Pharmacy & Surgical) ($M)40 periods
- Hospital Cost Structure — Other Operating Expenses (Contract Services, Utilities, Insurance, Rent) ($M)40 periods
- Non-GAAP Profitability — Adjusted EBITDA ($M)19 periods
- Professional Liability Reserves — Net Reserves (Net of Reinsurance Recoverable) at December 31 ($M)12 periods
4. Geographic Operating Group Performance — American, Atlantic, National & Corporate/UK (Note 12 XBRL & DB)
- American Group (TX, CO, KS, MO, LA, UT, ID, AK) — Segment Revenues ($M)37 periods
- Atlantic Group (FL, TN, NC, SC, VA, NH, KY) — Segment Revenues ($M)18 periods
- National Group (CA, NV, GA, FL-West, VA-North, etc.) — Segment Revenues ($M)37 periods
- Corporate and Other (including United Kingdom Operations) — Revenues ($M)37 periods
5. Clinical Quality Scorecard, Patient Experience, Workforce & CEO Pay Ratio (DEF 14A Proxy Statements, FY2022–FY2025)
6. Hospital Peer XBRL Benchmarks (UHS, CYH, EHC, ACHC, SGRY, ENSG, DVA) & U.S. Healthcare Macro Indicators (FRED & CMS)
- Hospital Peer — Universal Health Services (UHS): Total Revenues ($M)42 periods
- Hospital Peer — Community Health Systems (CYH): Total Revenues ($M)42 periods
- Post-Acute / Rehab Peer — Encompass Health Corporation (EHC): Total Revenues ($M)42 periods
- Behavioral Health Peer — Acadia Healthcare Company (ACHC): Total Revenues ($M)41 periods
- Ambulatory Surgery Peer — Surgery Partners, Inc. (SGRY): GAAP Operating Income ($M)40 periods
- Skilled Nursing Peer — The Ensign Group (ENSG): Total Revenues ($M)39 periods
- Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M)42 periods
- Managed Care Payer Benchmarks — UnitedHealth Group (UNH): Total Revenues ($M)42 periods
- U.S. Census QSS — Hospitals Taxable Employer Revenue (NAICS 622, NSA) ($M)42 periods
- BLS Healthcare Inflation — CPI: Hospital and Related Services (SA, Index) (×)128 periods
- BLS Healthcare Labor Market — All Employees: Hospitals (SA, thousands)129 periods
- CMS National Medicaid — Total U.S. Medicaid Enrollees (Annual July Snapshot)9 periods
7. Consolidated Financial Statements, Lease & Debt Schedules (PostgreSQL DB via lib.db & XBRL, through Q3 2026)
- DB Consolidated Income Statement — Total Revenues ($M)40 periods
- DB Consolidated Balance Sheet — Total Assets ($M)42 periods
- DB Consolidated Cash Flow — Net Cash Provided by Operating Activities ($M)42 periods
- Debt Structure & Lease Maturity — Gross Debt Principal / Carrying Value (XBRL) ($M)42 periods